Debut Plus

₹1,770

▼ -18.42 -1.03%

17 Jul 2026

NSE Listed · Pharmaceuticals

ASM 4

Venus Remedies Limited (VENUSREM)

Volume: 1,664Avg Vol 1W: 19,823Avg Vol 1M: 28,17652W Range:₹424₹2,044.3
NSE BSE www.venusremedies.com
Key Ratios
Checked just now
Market Cap₹2,366 Cr
Current Price₹1,770
Previous Close₹1,788.42
High / Low (52w)₹2,044.3 / ₹424
Volume1,664
Avg Vol (1W)19,823
Avg Vol (1M)28,176
Stock P/E23.02
Book Value₹496.56
Dividend Yield56%
ROE15.49%
ROA12.04%
Revenue (TTM)—
Revenue Growth7.72%
Profit Margin13.36%
Total Debt₹0 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹76.9
P/B3.56
Debt / Equity0.04
50 DMA₹1,793.43
200 DMA₹1,193.41
Day change-1.03%
SurveillanceASM 4 (as of 2026-07-17)
Price Chart
₹1,770▲ 146.93% · 1Y
₹1984₹4824.6L
2025-11-24
2026-07-17

20-day avg volume: 28K shares

Pros
  • Healthy return on equity of 15.5%.
  • Pays a dividend yield of 56.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹109 Cr₹170 Cr₹177 Cr₹195 Cr₹137 Cr₹193 Cr₹180 Cr₹259 Cr
EBITDA₹7 Cr₹9 Cr₹15 Cr₹31 Cr₹13 Cr₹27 Cr₹33 Cr₹62 Cr
Net Profit₹1 Cr₹4 Cr₹20 Cr₹21 Cr₹10 Cr₹20 Cr₹26 Cr₹48 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹375 Cr₹328 Cr₹345 Cr₹568 Cr₹608 Cr₹566 Cr₹613 Cr₹669 Cr
EBITDA₹8 Cr₹5 Cr₹14 Cr₹38 Cr₹37 Cr₹38 Cr₹45 Cr₹62 Cr
Net Profit₹-31 Cr₹-29 Cr₹-10 Cr₹62 Cr₹41 Cr₹27 Cr₹28 Cr₹45 Cr
EPS-24.87-23.16-8.150.0430.8619.8821.3133.9
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹751 Cr₹733 Cr₹644 Cr₹556 Cr₹580 Cr₹601 Cr₹627 Cr₹716 Cr
Total Liabilities₹389 Cr₹400 Cr₹320 Cr₹156 Cr₹139 Cr₹141 Cr₹139 Cr₹155 Cr
Equity₹362 Cr₹333 Cr₹323 Cr₹400 Cr₹440 Cr₹460 Cr₹488 Cr₹561 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹31 Cr₹45 Cr₹63 Cr₹108 Cr₹41 Cr₹37 Cr₹53 Cr₹101 Cr
Investing₹-11 Cr₹-11 Cr₹-5 Cr₹56 Cr₹-17 Cr₹-51 Cr₹-7 Cr₹-76 Cr
Financing₹-39 Cr₹-35 Cr₹-73 Cr₹-162 Cr₹-9 Cr₹-1 Cr₹-1 Cr₹-1 Cr
Free Cash Flow₹18 Cr₹45 Cr₹63 Cr₹108 Cr₹41 Cr₹37 Cr₹53 Cr₹101 Cr
Shareholding
Promoter 41.76% Institutions 4% Public 54.24%
Efficiency & Working Capital
ROCE19.8%
Interest Coverage862.1
Dividend Payout—
Debtor Days63 d
Inventory Days57 d
Payable Days52 d
Cash Conversion Cycle68 d
Working Capital Days120 d
Shareholding Details

As of 2026-03-31

Promoter41.8%
FII2.8%
DII1.2%
Institutions4%
Public54.2%
Promoter Pledge0%
No. of Shareholders18,403
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters41.8%41.8%41.8%41.8%41.8%41.8%41.8%41.8%41.8%41.8%41.8%41.8%
FIIs1%1%1.6%1.5%1.1%1.2%1.1%1.3%2.2%1.9%2.3%2.8%
DIIs0.2%0.1%0.1%0.1%0.1%0.1%0%0%0.1%0.7%1%1.2%
Public57.1%57.1%56.5%56.6%57%56.9%57.1%56.9%55.9%55.6%55%54.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders20,49819,26719,56019,91319,61419,55719,77119,98219,30717,72518,60618,403
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sunev Pharma Solutions Private LimitedShareholding of Promoter and Promoter Group17.2%23,00,000
Pawan ChaudharyShareholding of Promoter and Promoter Group12.8%17,13,946
Manu ChaudharyShareholding of Promoter and Promoter Group11.7%15,68,000
Tikri Partners LlpPublic Shareholding2%2,62,700
Rajni Tarun JainPublic Shareholding1.4%1,90,000
K.b.shekarPublic Shareholding1.4%1,90,000
Acadian Emerging Markets Micro-cap Equity Master FundPublic Shareholding1.1%1,47,501
Nisarg Ajaykumar VakhariaPublic Shareholding1.1%1,40,000
Peeyush JainShareholding of Promoter and Promoter Group0%50
Akshansh ChaudharyShareholding of Promoter and Promoter Group0%1
Ashutosh JainShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Pawan Chaudhary00%2026-03-31
Manu Chaudhary00%2026-03-31
Peeyush Jain00%2026-03-31
Akshansh Chaudhary00%2026-03-31
Ashutosh Jain00%2026-03-31
Sunev Pharma Solutions Private Limited00%2026-03-31
Acadian Emerging Markets Micro-cap Equity Master Fund00%2026-03-31
K.b.shekar00%2026-03-31
Nisarg Ajaykumar Vakharia00%2026-03-31
Rajni Tarun Jain00%2026-03-31
Tikri Partners Llp00%2026-03-31
Pawan Chaudhary00%2025-12-31
Board of Directors
NameDesignationYear
Pawan ChaudharyChairman / WTD / Managing Director / CFO2025
Manu ChaudharyWhole Time Director & JMD2025
Peeyush JainWhole Time Director / Deputy Managing Director2025
Ashutosh JainE D & Wholetime Director2025
Akshansh ChaudharyWhole Time Director & CTO2025
Navdeep SudIndependent Director2025
Savita GuptaIndependent Director2025
Pravindra Singh ChauhanIndependent Non Exe. Director2025
Nps MongaIndependent Non Exe. Director2025
Anil KumarIndependent Non Exe. Director2025
Jagdish Chander SharmaIndependent Non Exe. Director2025
Neha AroraCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Formulation₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201313
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-20Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025300051551
20250000-22-22
2025000044
Insider / Designated-Person Trades

3 recent disclosure(s)

PAWAN CHAUDHARYAcquisition · 1,26,946
PAWAN CHAUDHARY RevisedAcquisition · 6,00,000
MANU CHAUDHARY RevisedAcquisition · 4,25,000
Company Information
Incorporated1989
ChairmanPawan Chaudhary
AuditorJ K Jain & Associates
Investor Email[email protected]; complianceoff
🌐 www.venusremedies.com ↗

📍 S C No 857 Cabin No 10 2nd Flr, N A C Manimajra, Chandigarh, Chandigarh, 160101

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Veekayem Fash & App Ltd.Veljan Denison Ltd.Vels Film International LimitedVenky S (India) LimitedVentive Hospitality Ltd.Venus Pipes & Tubes Ltd.Vera Synthetic LimitedVeranda Learning Sol Ltd.Veritaas Advertising Ltd.Vertexplus Technologies LimitedVertis Infrastructure TstVertoz LimitedAll “V” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search